Detalhe da pesquisa
1.
Predictors of DAPSA28 remission in patients with psoriatic arthritis initiating a first TNF inhibitor: results from 13 European registries.
Rheumatology (Oxford)
; 63(3): 751-764, 2024 Mar 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37314967
2.
Patient-Reported Outcomes (PROs) and PRO Remission Rates in 12,262 Biologic-Naïve Patients With Psoriatic Arthritis Treated With Tumor Necrosis Factor Inhibitors in Routine Care.
J Rheumatol
; 51(4): 378-389, 2024 Apr 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38224992
3.
Conversion of the MDHAQ to the HAQ score: a simple algorithm developed and validated in a cohort of 13â391 real-world patients.
Rheumatology (Oxford)
; 61(10): 3919-3929, 2022 10 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-35108380
4.
Sex Differences in the Effectiveness of First-Line Tumor Necrosis Factor Inhibitors in Psoriatic Arthritis: Results From the European Spondyloarthritis Research Collaboration Network.
Arthritis Rheumatol
; 76(4): 587-598, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-37975166
5.
Commonalities and differences in set-up and data collection across European spondyloarthritis registries - results from the EuroSpA collaboration.
Arthritis Res Ther
; 25(1): 205, 2023 10 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-37858143
6.
Predictors of ASDAS-CRP inactive disease in axial spondyloarthritis during treatment with TNF-inhibitors: Data from the EuroSpA collaboration.
Semin Arthritis Rheum
; 56: 152081, 2022 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-35985172
7.
Real-World Six- and Twelve-Month Drug Retention, Remission, and Response Rates of Secukinumab in 2,017 Patients With Psoriatic Arthritis in Thirteen European Countries.
Arthritis Care Res (Hoboken)
; 74(7): 1205-1218, 2022 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-33460531
8.
Analysing and reporting of observational data: a systematic review informing the EULAR points to consider when analysing and reporting comparative effectiveness research with observational data in rheumatology.
RMD Open
; 7(3)2021 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-34789534
9.
Investigation of potential non-HLA rheumatoid arthritis susceptibility loci in a European cohort increases the evidence for nine markers.
Ann Rheum Dis
; 69(8): 1548-53, 2010 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-20498205
10.
Corrigendum to 'Predictors of ASDAS-CRP inactive disease in axial spondyloarthritis during treatment with TNF-inhibitors: data from the EuroSpA collaboration' [Seminars in Arthritis and Rheumatism 56 (2022) 1-13/152081].
Semin Arthritis Rheum
; 58: 152141, 2023 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-36463635
11.
Identification of the tyrosine-protein phosphatase non-receptor type 2 as a rheumatoid arthritis susceptibility locus in europeans.
PLoS One
; 8(6): e66456, 2013.
Artigo
em Inglês
| MEDLINE | ID: mdl-23840476